Feds investigate Walgreens pharmacies in drug diversion probe | More employers choose to self-insure | Democratic leaders rule out benefit cuts in sequestration talks
Web Version
 
 
November 29, 2012
FOLLOW PCMA ON TWITTER  Twitter
PCMA SmartBrief
News for the PBM Industry
SIGN UP|FORWARD|ARCHIVE

Featured Story
Feds investigate Walgreens pharmacies in drug diversion probe
The Drug Enforcement Administration is investigating three Walgreens pharmacies in Florida as part of a broader prescription drug abuse probe. The pharmacies must now prove they are eligible to keep their licenses. Reuters (11/28)
Share: LinkedInTwitterFacebookGoogle+Email
Registration is now open for PCMA's Managed Markets Educational Forum!
Whether you are a seasoned managed markets executive or someone who supports the team, PCMA's Managed Markets Educational Forum will provide valuable education on fundamental, as well as complex and strategic issues relevant to professionals of all levels within pharma managed markets or market access divisions. Visit PCMA's website to learn more about our 2013 events!
Advertisement
 
Legislative & Regulatory News
More employers choose to self-insure
About 60% of private-sector employees were covered by a self-insured health plan last year, compared with about 40% in the late 1990s, according to the Employee Benefit Research Institute. "Employers generally, and small employers particularly, concerned about the rising cost of providing health coverage may view self-insurance as a better way to control expected cost increases," according to Paul Fronstin, who wrote the EBRI report. The Hill/Healthwatch blog (11/28)
Share: LinkedInTwitterFacebookGoogle+Email
Democratic leaders rule out benefit cuts in sequestration talks
Democrats will not consider reducing Medicare benefits as part of a deal to avoid sequestration, party leaders said. "The moment you want to privatize Social Security or voucherize Medicare or block-grant Medicaid -? that's where you lose us," said Rep. Xavier Becerra, D-Calif. Democrats said they would consider ways to reduce waste and inefficiencies in the system. The Hill (11/28)
Share: LinkedInTwitterFacebookGoogle+Email
HHS inspector general faults Medicare for EHR safeguards
Medicare officials have not developed sufficient safeguards for EHRs, leaving the data vulnerable to abuse and fraud, an HHS Office of Inspector General report found. The New York Times (tiered subscription model) (11/29)
Share: LinkedInTwitterFacebookGoogle+Email
More doctors e-prescribe using EHRs, report finds
A report from the Office of the National Coordinator for Health IT found that 48% of physicians in the U.S. were e-prescribing using EHR systems as of June 2012, compared with 7% in December 2008. Pharmacy participation in e-prescribing and higher rates of doctors who meet meaningful use objectives contributed to the increase, according to the report. BeckersHospitalReview.com (11/28)
Share: LinkedInTwitterFacebookGoogle+Email
PBM Industry News
Formulary flexibility will benefit patients, PCMA says
Although a proposed rule requiring health insurance plans sold on exchanges to cover the same number of drugs in each class as the state's benchmark could benefit drugmakers, Jill Wechsler writes, it does not establish "protected drug classes." Giving insurers more flexibility to design clinically based formularies will let them offer "more affordable, generous prescription drug benefits," the Pharmaceutical Care Management Association says. PharmExec.com/PharmExecBlog (11/28)
Share: LinkedInTwitterFacebookGoogle+Email
Drug Industry Spotlight
Civil suits against NECC may proceed, judge rules
U.S. District Judge Dennis Saylor allowed civil lawsuits to proceed against the New England Compounding Center, the compounding pharmacy tied to a nationwide meningitis outbreak. Criminal cases would have priority in collecting evidence, Saylor said. Reuters (11/28)
Share: LinkedInTwitterFacebookGoogle+Email
Perrigo, Cobrek get FDA nod for generic Luxiq foam
Perrigo and Cobrek Pharmaceuticals received regulatory approval for the 0.12% formulation of betamethasone validate foam to address scalp psoriasis. The treatment is the generic version of Stiefel Labs' Luxiq foam. Drug Store News (11/28)
Share: LinkedInTwitterFacebookGoogle+Email
SmartQuote
We acquire the strength we have overcome."
-- Ralph Waldo Emerson,
American writer
Share: LinkedInTwitterFacebookGoogle+Email
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 216 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

Contact PCMA
Charles Cote
Vice President, Strategic Communications
(202) 207-3610
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
 
Editor:  Melissa Turner
 
 

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information